与以往的疗法相比，ET- 1受体拮抗剂被认为是治疗肺动脉高压最有前景的新药。

Till now, ET-1 receptor antagonist is the most promising drug that can be used for pulmonary hypertension.

youdao

与以往的疗法相比，ET- 1受体拮抗剂被认为是治疗肺动脉高压最有前景的新药。

Till now, ET-1 receptor antagonist is the most promising drug that can be used for pulmonary hypertension.

youdao